Synapse - Works

Results (58)

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer

Journal Article

Milowsky, M. I.; Galsky, M. D.; Morris, M. J.; Crona, D. J.; George, D. J.; Dreicer, R.; Tse, K.; Petruck, J.; Webb, I. J.; Bander, N. H.; more...
Urologic Oncology: Seminars and Original Investigations (2016)

Fulltext@MSK | Save

Phase I trial of gemcitabine and split-dose cisplatin plus everolimus (RAD001) in patients with advanced urothelial cancer

Meeting Abstract

Abida, W.; Milowsky, M. I.; Ostrovnaya, I.; Gerst, S. R.; Rosenberg, J. E.; Regazzi, A. M.; McCoy, A. S.; Boyd, M. E.; Bajorin, D. F.
Journal of Clinical Oncology (2015)

Fulltext@MSK | Save

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma (UC) based on the impact of prognostic factors

Meeting Abstract

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Comparative effectiveness of gemcitabine plus cisplatin (GC) versus methotrexate, vinblastine, doxorubicin, plus cisplatin (MVAC) as neoadjuvant therapy for muscle-invasive bladder cancer (MIBC)

Meeting Abstract

Galsky, M. D.; Harshman, L. C.; Crabb, S. J.; Wong, Y. N.; Yu, E. Y.; Chowdhury, S.; Powles, T.; Pal, S. K.; Moshier, E. L.; Ladoire, S.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Impact of prior platinum agent and site of primary in patients with advanced urothelial carcinoma (UC) receiving salvage therapy

Meeting Abstract

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Impact of number of lines of prior chemotherapy in patients (pts) with advanced urothelial carcinoma (UC) receiving salvage therapy

Meeting Abstract

Sonpavde, G.; Bellmunt, J.; Rosenberg, J. E.; Bajorin, D. F.; Regazzi, A. M.; Choueiri, T. K.; Qu, A. Q.; Niegisch, G.; Albers, P.; Necchi, A.; more...
Journal of Clinical Oncology (2014)

Fulltext@MSK | Save

Phase II study of lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancer

Journal Article

Tagawa, S. T.; Milowsky, M. I.; Morris, M.; Vallabhajosula, S.; Christos, P.; Akhtar, N. H.; Osborne, J.; Goldsmith, S. J.; Larson, S.; Taskar, N. P.; more...
Clinical Cancer Research (2013)

Fulltext@MSK | Save

Germline single nucleotide polymorphisms associated with response of urothelial carcinoma to platinum-based therapy: The role of the host

Journal Article

Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Iyer, G.; Garcia-Grossman, I. R.; Kim, P. H.; Przybylo, J. A.; Alanee, S.; Riches, J. C.; more...
Annals of Oncology (2013)

Fulltext@MSK | Save

Phase II study of everolimus in metastatic urothelial cancer

Journal Article

Milowsky, M. I.; Iyer, G.; Regazzi, A. M.; Al-Ahmadie, H.; Gerst, S. R.; Ostrovnaya, I.; Gellert, L. L.; Kaplan, R.; Garcia-Grossman, I. R.; Pendse, D.; more...
BJU International (2013)

Fulltext@MSK | Save

Phase ii study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer

Journal Article

Balar, A. V.; Apolo, A. B.; Ostrovnaya, I.; Mironov, S.; Iasonos, A.; Trout, A.; Regazzi, A. M.; Garcia-Grossman, I. R.; Gallagher, D. J.; Milowsky, M. I.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save